HCW Biologics Secures up to $10.0 Million in Cash Through Debt Financing
Provides funding needed to complete HCW9302 Phase 1 study in alopecia areata and establish Recommended Phase 2 Dose Provides funding needed to complete HCW9302 Phase 1 study in alopecia areata and establish Recommended Phase 2 Dose
Covered in this story
Call it yourself
No calls on $HCWB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on HCW Biologics →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.